Pyxis Oncology(PYXS) - 2024 Q3 - Quarterly Report
Pyxis Oncology(PYXS)2024-11-12 12:43UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-40881 | --- | --- | |----------------------------------------------------------------------------|------------------------------------------| | Pyxis Oncology, ...